{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:58:23Z","timestamp":1787061503174,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Unsupervised machine learning shows significant promise for evaluating multicolor flow cytometry, particularly in advancing minimal residual disease (MRD) analysis. We implemented t-distributed stochastic neighbor embedding (t-SNE)-assisted MRD analysis in a challenging case of Philadelphia chromosome-positive acute lymphoblastic leukemia. This approach enabled us to identify MRD on an unbiased basis with a sensitivity comparable to that of genetic analysis while simultaneously reducing the workload. t-SNE is a valuable tool for the detection and verification of MRD, with its effectiveness significantly enhanced through the integration of optimized antibody panels, data preprocessing, and rigorous back-gating verification.<\/jats:p>","DOI":"10.1097\/mph.0000000000003142","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:03:24Z","timestamp":1762434204000},"page":"e21-e25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Optimized Flow Cytometry Incorporating t-SNE Enables Minimal Residual Disease Assessment in a Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia at or Near the Lower Detection Limit"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5691-1928","authenticated-orcid":false,"given":"Kenichiro","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Mizuta","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7567-9999","authenticated-orcid":false,"given":"Yuka","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kuroda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Okuda","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, Biosciences, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, Biosciences, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Ikuo","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company, Biosciences, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Maihara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ueshimo","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuya","family":"Usami","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"},{"name":"Pediatric Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Heike","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusei","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hyogo Prefectural Amagasaki General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"R1-20251230","doi-asserted-by":"crossref","first-page":"e170580","DOI":"10.1001\/jamaoncol.2017.0580","article-title":"Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis","volume":"3","author":"Berry","year":"2017","journal-title":"JAMA Oncol"},{"key":"R2-20251230","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cyto.b.20430","article-title":"Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: multicentric assessment is feasible","volume":"74","author":"Dworzak","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"R3-20251230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cyto.b.20532","article-title":"Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia","volume":"78","author":"Luria","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"R4-20251230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41379-020-00677-7","article-title":"Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study","volume":"34","author":"Lhermitte","year":"2021","journal-title":"Mod Pathol"},{"key":"R5-20251230","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cyto.a.23852","article-title":"Automated flow cytometric MRD assessment in childhood acute B- lymphoblastic leukemia using supervised machine learning","volume":"95","author":"Reiter","year":"2019","journal-title":"Cytometry A"},{"key":"R6-20251230","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/cyto.b.22084","article-title":"Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual disease analysis","volume":"102","author":"Shopsowitz","year":"2022","journal-title":"Cytometry B Clin Cytom"},{"key":"R7-20251230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","article-title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","volume":"129","author":"Theunissen","year":"2017","journal-title":"Blood"},{"key":"R8-20251230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cyto.a.24670","article-title":"flowCut: an R package for automated removal of outlier events and flagging of files based on time versus fluorescence analysis","volume":"103","author":"Meskas","year":"2023","journal-title":"Cytometry A"},{"key":"R9-20251230","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"key":"R10-20251230","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"key":"R11-20251230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nbt.2594","article-title":"viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia","volume":"31","author":"Amir el","year":"2013","journal-title":"Nat Biotechnol"},{"key":"R12-20251230","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/s41467-019-13055-y","article-title":"Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets","volume":"10","author":"Belkina","year":"2019","journal-title":"Nat Commun"},{"key":"R13-20251230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.leukres.2013.10.008","article-title":"Significance of CD66c expression in childhood acute lymphoblastic leukemia","volume":"38","author":"Kiyokawa","year":"2014","journal-title":"Leuk Res"},{"key":"R14-20251230","doi-asserted-by":"crossref","first-page":"112429","DOI":"10.1016\/j.jim.2018.03.005","article-title":"Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia","volume":"475","author":"Sedek","year":"2019","journal-title":"J Immunol Methods"},{"key":"R15-20251230","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cyto.b.21252","article-title":"Detection of minimal residual disease in B lymphoblastic leukemia using viSNE","volume":"88","author":"DiGiuseppe","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"issue":"Suppl 1","key":"R16-20251230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ijlh.13548","article-title":"Unsupervised flow cytometry analysis in hematological malignancies: a new paradigm","volume":"43","author":"Bene","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"R17-20251230","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3389\/fimmu.2019.01194","article-title":"Quantitative comparison of conventional and t-SNE-guided gating analyses","volume":"10","author":"Toghi Eshghi","year":"2019","journal-title":"Front Immunol"},{"key":"R18-20251230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ejh.14102","article-title":"15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia\/lymphoma: real-world applicability and challenges","volume":"112","author":"Chatterjee","year":"2024","journal-title":"Eur J Haematol"},{"key":"R19-20251230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cyto.b.22113","article-title":"Flow cytometric assessment for minimal\/measurable residual disease in B lymphoblastic leukemia\/lymphoma in the era of immunotherapy","volume":"104","author":"Chen","year":"2023","journal-title":"Cytometry B Clin Cytom"},{"key":"R20-20251230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cyto.b.21482","article-title":"A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia\/lymphoma post anti-CD19 therapy","volume":"94","author":"Cherian","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"R21-20251230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cyto.b.22166","article-title":"Recommendations for using artificial intelligence in clinical flow cytometry","volume":"106","author":"Ng","year":"2024","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:00:33Z","timestamp":1767110433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003142","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"2025-01-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}